Site search
2898 results for '' found
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants with Chronic Primary Immune Thrombocytopenia (N
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants with Chronic Primary Immune Thrombocytopenia (N
/
A Phase 1 study of TAS-116 (pimitespib) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (NCT05245968)
A Phase 1 study of TAS-116 (pimitespib) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (NCT05245968)
/
The Syncope-Stopper study: comparison of upfront pacing with standard care for high-risk patients with unexplained syncope. (ACTRN12622001553763)
The Syncope-Stopper study: comparison of upfront pacing with standard care for high-risk patients with unexplained syncope. (ACTRN12622001553763)
/
Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy and symptom control, on quality of life in patients with pancreatic cancer: a randomise
Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy and symptom control, on quality of life in patients with pancreatic cancer: a randomise
/
A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (NCT05359861)
A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (NCT05359861)
/
A Phase I/III Randomized, Double-blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing I
A Phase I/III Randomized, Double-blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing I
/
A Phase 2, Multicenter, Open Label Safety and Tolerability Study of SPN-817 in Adult Patients with Treatment Resistant Epilepsy (NCT05518578)
A Phase 2, Multicenter, Open Label Safety and Tolerability Study of SPN-817 in Adult Patients with Treatment Resistant Epilepsy (NCT05518578)
/
Solving Unknown Primary cancER Earlier Diagnosis [SUPER-ED]: A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis (ACTRN12622001504707)
Solving Unknown Primary cancER Earlier Diagnosis [SUPER-ED]: A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis (ACTRN12622001504707)
/